About admin

This author has not yet filled in any details.
So far admin has created 592 blog entries.

Pharming announces further issue of shares as employee options are exercised

Management exercise options representing 6,240,000 shares and as result increase their holdings by 26% Leiden, The Netherlands, 30 July 2018: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) announced today that it has issued a total of 6,240,000 new shares following exercise of warrants representing a total of 6,240,000 shares. The new shares [...]

Pharming Group Halfjaarbericht 2018

Recordomzet uit productverkopen; stijging met 96% ten opzichte van het eerste halfjaar 2017 Pharming boekt eerste halfjaar uit historie met nettowinst Uitbreiding pijplijn van nieuwe producten plus nieuwe grote indicaties en doseringsvormen voor RUCONEST® Leiden, 26 juli 2018: Pharming Group N.V. (“Pharming” of “de Onderneming”) (Euronext Amsterdam: PHARM) maakt haar (niet-gecontroleerde) resultaten over de eerste [...]

Pharming Reports on Financial Results for the First Half of 2018

Record revenue from product sales, up 96% on 2017 Pharming’s first half year of net profitability Expanding pipeline of new products plus new large indications and dosage forms for RUCONEST® Leiden, The Netherlands, 26 July 2018: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) presents its (unaudited) financial report for the six months [...]

Capital Market Briefing recording and slide deck

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) held its first Capital Markets Briefing from 08:00 to 10:30 EST/14:00-16:30 CET on 21 June 2018 in New York, NY, and through a live webcast. To re-watch the webinar please click here: https://www.webcaster4.com/Player/Index?webcastId=26283&uid=4540030&g=e6bd1a0c-4690-4fce-950b-168e798ed2ca&sid= For a copy of the slide deck please click here: https://www.pharming.com/wp-content/uploads/2018/06/CMB-21-June.pdf During [...]

Sign up for Pharming’s Capital Markets Briefing – Webinar details inside

Pharming Capital Markets Briefing 21 June 2018, New York Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) announces its Capital Markets Briefing to be held from 08:00 to 10:30 EST/14:00-16:30 CET on 21 June 2018 in New York, NY, and through a live webcast. To follow the webinar, live please sign up here: https://www.webcaster4.com/Webcast/Page/359/26283 [...]

Pharming publiceert agenda voor de Capital Markets Briefing op 21 juni 2018 in New York

Nieuwe toedieningsvormen RUCONEST® bij erfelijk angio-oedeem Uitbreiding klinische ontwikkeling rhC1INH bij pre-eclampsie (zwangerschapsvergiftiging), contrast-geïnduceerde nefropathie en andere potentiële grote indicaties Klinische ontwikkeling eiwit vervangende producten bij de ziekten van Pompe en Fabry Leiden, 5 juni 2018 - Pharming Group NV ("Pharming" of "de Onderneming") (Euronext Amsterdam: PHARM), publiceert de agenda voor haar Capital Markets Briefing [...]

Pharming announces Agenda for its Capital Markets Briefing to be held on 21 June 2018 in New York

New forms of administration for RUCONEST® for HAE Expansion of rhC1INH clinical development in pre-eclampsia, contrast induced nephropathy and other potential large indications Clinical development of protein replacement products in Pompe and Fabry diseases Leiden, The Netherlands, 05 June 2018, Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) announces the agenda for its [...]

Pharming Reports On Annual General Meeting Of Shareholders

Mr. Jaap Blaak, Former Chairman of the Board of Supervisory Directors, retires from the Board Leiden, The Netherlands, 23 May 2018, Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) announces that at its Annual General Meeting of shareholders (AGM), held today, all proposals were approved. At the meeting, Mr. Jaap Blaak, who was [...]

Pharming Group publiceert financiële resultaten over het eerste kwartaal van 2018

93% hogere omzet uit productverkopen en 110% hogere operationele winst in vergelijking met het eerste kwartaal van 2017 Voor de eerste maal netto-winstgevendheid voor Pharming Leiden, 17 mei 2018: Pharming Group N.V. (“Pharming” of “de Onderneming”) (Euronext Amsterdam: PHARM) maakt haar (niet-gecontroleerde) resultaten over het eerste kwartaal 2018 eindigend op 31 maart bekend. Operationele hoofdpunten [...]

Pharming Group Interim Report on Financial Results for the First Quarter 2018

93% increase in revenues from product sales and 110% increase in operating profit compared with the First Quarter 2017 Delivered net profitability for the first time Leiden, The Netherlands, 17 May 2018: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) presents its (unaudited) financial report for the quarter ended 31 March 2018. Operational [...]